Weekly Headlines: Aldeyra Reports New Phase 3 Data for DED Drug Candidate Reproxalap
Aldeyra Reports New Phase 3 Data for DED Drug Candidate Reproxalap • Lensar Receives European Approval for ALLY System • Lenz Therapeutics Submits NDA for Presbyopia Eye Drop